Down-regulation of the inhibitors of vascular mineralization, such as matrix Gla protein or fetuin-A, is associated with increased vascular calcification and consequent mortality due to cardiovascular dysfunction in patients with CKD [29,30]. This evidence concerns the gene AHSG and chronic kidney disease.